Robert Schlossman
Impact in
- Hematology top 0.05%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Oncology top 0.2%
- Peptidase Inhibition and Analysis
Papers in
- Hematology 134
- Multiple Myeloma Research and Treatments 123
- Hematopoietic Stem Cell Transplantation 16
-
- Protein Degradation and Inhibitors 50
- Ubiquitin and proteasome pathways 10
- Co-authors
- Kenneth C. Anderson (134 shared papers)Paul G. Richardson (124 shared papers)Teru Hideshima (57 shared papers)Dharminder Chauhan (37 shared papers)Nikhil C. Munshi (89 shared papers)Constantine S. Mitsiades (46 shared papers)Nicholas Mitsiades (21 shared papers)Steven P. Treon (18 shared papers)
- Journals
- Blood (84 papers)Journal of Clinical Oncology (12 papers)British Journal of Haematology (10 papers)Biology of Blood and Marrow Transplantation (5 papers)Cancer Research (4 papers)
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
Robert Schlossman
160 papers receiving 10.7k citations
Robert Schlossman's Hit Papers
Peers
Comparison fields: 5 of 127
- Hematology 6.7k
- Oncology 4.1k
- Genetics 1.2k
- Molecular Biology 6.0k
- Immunology 1.6k
Countries citing papers authored by Robert Schlossman
This map shows the geographic impact of Robert Schlossman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Schlossman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Schlossman more than expected).
Fields of papers citing papers by Robert Schlossman
This network shows the impact of papers produced by Robert Schlossman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Schlossman. The network helps show where Robert Schlossman may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Schlossman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 162 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma Hit paper breakdown → | 2001 | 744 |
| 2 | Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy Hit paper breakdown → | 2000 | 711 |
| 3 | Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma Hit paper breakdown → | 2002 | 632 |
| 4 | The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications Hit paper breakdown → | 2003 | 574 |
| 5 | 2003 | 475 | |
| 6 | 2002 | 397 | |
| 7 | 2001 | 327 | |
| 8 | 2001 | 320 | |
| 9 | 1999 | 280 | |
| 10 | 1998 | 253 | |
| 11 | 2003 | 252 | |
| 12 | 2010 | 239 | |
| 13 | 2013 | 230 | |
| 14 | 2009 | 202 | |
| 15 | 2006 | 190 | |
| 16 | 2003 | 188 | |
| 17 | 2006 | 183 | |
| 18 | 2001 | 165 | |
| 19 | 2005 | 159 | |
| 20 | 2001 | 153 |
About Robert Schlossman
Robert Schlossman is a scholar working on Hematology, Molecular Biology, Oncology, Pathology and Forensic Medicine and Immunology, having authored 162 papers that have together received 10.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (123 papers), Protein Degradation and Inhibitors (50 papers), Peptidase Inhibition and Analysis (33 papers), Hematopoietic Stem Cell Transplantation (16 papers), Cancer Treatment and Pharmacology (16 papers), Cancer Mechanisms and Therapy (14 papers), Immunotherapy and Immune Responses (12 papers) and Ubiquitin and proteasome pathways (10 papers). The work is most often cited by research in Hematology (6.7k citations), Oncology (4.1k citations), Genetics (1.2k citations), Molecular Biology (6.0k citations) and Immunology (1.6k citations). Robert Schlossman has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Kenneth C. Anderson, Paul G. Richardson, Teru Hideshima, Dharminder Chauhan, Nikhil C. Munshi, Constantine S. Mitsiades, Nicholas Mitsiades, Steven P. Treon, Yu‐Tzu Tai and Klaus Podar. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Biology of Blood and Marrow Transplantation and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.